193 resultados para Feno


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Pós-graduação em Zootecnia - FCAV

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Pós-graduação em Agronomia (Energia na Agricultura) - FCA

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Pós-graduação em Zootecnia - FCAV

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Relevância:

20.00% 20.00%

Publicador:

Resumo:

This work aimed to evaluate the carcass yields, commercial cuts and non-carcass components of Santa Inês lambs fed with 30, 40, 50 or 60% of oldman saltbush hay with concentrated. Were used 32 castrated lambs at 8 months old and initial body weight of 22 + 1.97kg, housed individually and slaughtered after 60 days of feedlot. The weights of hot and cold carcass decreased linearly with the inclusion of saltbush hay in the diet, however, there was no effect for true carcass yield and commercial cuts: shoulder (19.26%), neck (8.52%) ribs (26.57%) and leg (33.88%). There was a linear decrease for ribeye area and fat thickness when the level of hay in the diet increased. The weights and yields of skin, liver, heart, kidneys with perirenal fat, omental and mesenteric fats decreased linearly with the inclusion of hay in the diet, while the content (%) of gastrointestinal tract increased. The increased proportion of saltbush hay in the diet of lambs provided adequate true carcass yield and commercial cuts, however, reduces the ribeye area and fat thickness, important measurements in the qualitative evaluation of the lamb's carcass.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The trial was carried to evaluate the nutritional effects of mulberry leaf hay in broiler chickens. Five treatments were used: control (no mulberry, 3.16% CF); 15% mulberry (4.14% CF); 30% mulberry (5.09% CF), no mulberry (4.14% CF); no mulberry (5.09% CF). A randomized blocks design was used, with two blocks and three replications into the blocks to evaluate performance index, histopathological examination of the visceral organs and morphometric measurements of the hepatocyte nucleus and pancreatic acini. A poor performance index was observed for broilers feeding on mulberry leaves; lesions such as steatosis, proliferation of hepatic duct cells and multiple necrosis were found in the livers of the chickens fed with 30% mulberry (5.09% CF), as well as size reduction of the hepatocyte nucleus and pancreatic acini. From these data, it is concluded that mulberry probably has some toxic substance which can interfere in the improvement of diet ingredients, resulting in damage to broiler chickens.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The experiment was conducted to evaluate the feeding behavior of lambs fed with diets containing 0, 12.5 and 25.0% of mulberry hay as a substitute for the concentrate. Twenty four Ile de France lambs, non castrated, with 25 kg of body weight and four months old, confined, in a completely randomized design, were used. The feeding daily time (242.01 minutes), rumination (435.48 minutes) and leisure (762.50 minutes), the numbers of cakes ruminated per day (658.36) and the time spent per cake (40.03 sec) were not affected (P>0.05) by different levels of hay in mulberry concentrate. The dry matter voluntary intake (1.258 kg/day) and neutral detergent fiber intake (0.302 kg/day), as well as the efficiency of dry matter intake and rumination (316.24 and 173.54 g/h, respectively) and efficiency of neutral detergent fiber intake and rumination (75.89 and 41.68 g/h, respectively) were similar in all treatments. The ruminating chew expressed in hour/day (11.29) and the number of chews expressed per cake (72.65) and per day (47.638.06), as well as the number and the feeding time (22.02 meals and 11.23 min/meal), rumination (25.95 ruminations and 17.29 min/rumination) and idle (41.81 idle and 18.30 min/idle time), were also not affected (P>0.05). The inclusion of mulberry hay did not change the rumination expressed in g of DM and NDF/cake (1.91 and 0.46, respectively) and min/kg of DM and NDF (361.51 and 1.505.78, respectively), as well as the total chew expressed in min/kg of DM and NDF (563.70 and 2.347.19, respectively). The use of mulberry hay partially replacing the concentrated, does not change the feeding behavior of feedlot lambs.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The experiment was conducted to evaluate the intake, the digestibility and the performance of lambs fed with diets containing 0; 12,5 and 25% of mulberry hay in substitution of the concentrate. It was used a total of 24 lambs Ile de France breed, non castrated, average age 60 days and and 15 kg of body weight, confined, distributed in a completely randomized design. Voluntary intake of nutrients was not altered (P>0.05) by different percentages of mulberry hay inclusion in the concentrate, except ether extract which decreased linear (P<0.01). The digestibility of nutrients, days on feeding, daily weight gain and the feed conversion, were also not affected (P>0.05). The partial substitution of the concentrate, based on soybean meal and corn grain, by mulberry hay up to 25% does not compromise the intake, the digestibility of nutrients and the performance of diet of feedlot lambs.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Contribución como póster al Simposio de Ciencias de la Visión en la XI Reunión Nacional de Óptica

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Dissertação (mestrado)—Universidade de Brasília, Faculdade de Tecnologia, Departamento de Engenharia Mecânica, 2016.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Background The measurement of severity and control of asthma in both children and adults can be based on subjective or objective measures. It has been advocated that fractional exhaled nitric oxide (FeNO) can be used to monitor airway inflammation as it correlates with some markers of asthma. Interventions for asthma therapies have been traditionally based on symptoms and/or spirometry. Objectives To evaluate the efficacy of tailoring asthma interventions based on exhaled nitric oxide in comparison to clinical symptoms (with or without spirometry/peak flow) for asthma related outcomes in children and adults. Search methods We searched the Cochrane Airways Group Specialised Register of Trials, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and reference lists of articles. The last search was completed in February 2009. Selection criteria All randomised controlled comparisons of adjustment of asthma therapy based on exhaled nitric oxide compared to traditional methods (primarily clinical symptoms and spirometry/peak flow). Data collection and analysis Results of searches were reviewed against pre-determined criteria for inclusion. Relevant studies were independently selected in duplicate. Two authors independently assessed trial quality and extracted data. Authors were contacted for further information with response from one. Main results Two studies have been added for this update, which now includes six (2 adults and 4 children/adolescent) studies; these studies differed in a variety of ways including definition of asthma exacerbations, FeNO cut off levels, the way in which FeNO was used to adjust therapy and duration of study. Of 1053 participants randomised, 1010 completed the trials. In the meta-analysis, there was no significant difference between groups for the primary outcome of asthma exacerbations or for other outcomes (clinical symptoms, FeNO level and spirometry). In post-hoc analysis, a significant reduction in mean final daily dose inhaled corticosteroid per adult was found in the group where treatment was based on FeNO in comparison to clinical symptoms, (mean difference -450 mcg; 95% CI -677 to -223 mcg budesonide equivalent/day). However, the total amount of inhaled corticosteroid used in one of the adult studies was 11% greater in the FeNO arm. In contrast, in the paediatric studies, there was a significant increase in inhaled corticosteroid dose in the FeNO strategy arm (mean difference of 140 mcg; 95% CI 29 to 251, mcg budesonide equivalent/day). Authors' conclusions Tailoring the dose of inhaled corticosteroids based on exhaled nitric oxide in comparison to clinical symptoms was carried out in different ways in the six studies and found only modest benefit at best and potentially higher doses of inhaled corticosteroids in children. The role of utilising exhaled nitric oxide to tailor the dose of inhaled corticosteroids cannot be routinely recommended for clinical practice at this stage and remains uncertain.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Asthma severity and control can be measured both subjectively and objectively. Traditionally asthma treatments have been individualised using symptoms and spirometry/peak flow. Increasingly treatment tailored in accordance with inflammatory markers (sputum eosinophil counts or fractional exhaled nitric oxide (FeNO) data) is advocated as an alternative strategy. The objective of this review was to evaluate the efficacy of tailoring asthma interventions based on inflammatory markers (sputum analysis and FeNO) in comparison with clinical symptoms (with or without spirometry/peak flow) for asthma-related outcomes in children and adults. Cochrane Airways Group Specialised Register of Trials, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and reference lists of articles were searched. The last searches were in February 2009. All randomised controlled comparisons of adjustment of asthma treatment based on sputum analysis or FeNO compared with traditional methods (primarily clinical symptoms and spirometry/peak flow) were selected. Results of searches were reviewed against predetermined criteria for inclusion. Relevant studies were selected, assessed and data extracted independently by at least two people. The trial authors were contacted for further information. Data were analysed as 'intervention received' and sensitivity analyses performed. Six (2 adults and 4 children/adolescent) studies utilising FeNO and three adult studies utilising sputum eosinophils were included. These studies had a degree of clinical heterogeneity including definition of asthma exacerbations, duration of study and variations in cut-off levels for percentage of sputum eosinophils and FeNO to alter management in each study. Adults who had treatment adjusted according to sputum eosinophils had a reduced number of exacerbations compared with the control group (52 vs. 77 patients with >=1 exacerbation in the study period; p=0.0006). There was no significant difference in exacerbations between groups for FeNO compared with controls. The daily dose of inhaled corticosteroids at the end of the study was decreased in adults whose treatment was based on FeNO in comparison with the control group (mean difference -450.03 mug, 95% CI -676.73 to -223.34; p<0.0001). However, children who had treatment adjusted according to FeNO had an increase in their mean daily dose of inhaled corticosteroids (mean difference 140.18 mug, 95% CI 28.94 to 251.42; p=0.014). It was concluded that tailoring of asthma treatment based on sputum eosinophils is effective in decreasing asthma exacerbations. However, tailoring of asthma treatment based on FeNO levels has not been shown to be effective in improving asthma outcomes in children and adults. At present, there is insufficient justification to advocate the routine use of either sputum analysis (due to technical expertise required) or FeNO in everyday clinical practice.